CDKN2A and head and neck squamous cell carcinoma: In terms of their genomic alterations, HPV-negative HNSCC displays a high frequency of mutations in TP53 (83%) and CDKN2A (57%), as per data from The Cancer Genome Atlas (TCGA) of HNSCC [15].